首页> 美国卫生研究院文献>World Journal of Gastrointestinal Oncology >shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells via VEGF-C/PI3K/AKT signaling pathway
【2h】

shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells via VEGF-C/PI3K/AKT signaling pathway

机译:shRNA干扰LSD1通过VEGF-C / PI3K / AKT信号通路抑制胃癌细胞的增殖和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUNDHistone Lysine Specific Demethylase 1 (LSD1) is the first histone demethylase to be discovered, which regulates various biological functions by making lysine of histone H3K4, H3K9 and non-histone substrates demethylated. Abnormal regulation of LSD1 is closely related to the occurrence and development of gastric cancer. The change of LSD1 expression level plays an important role in the proliferation and metastasis of gastric cancer cells. The study of its function and mechanism may provide a theoretical basis for early diagnosis and targeted therapy of gastric cancer.
机译:背景组蛋白赖氨酸特异性脱甲基酶1(LSD1)是第一个被发现的组蛋白脱甲基酶,它通过使组蛋白H3K4,H3K9和非组蛋白底物的赖氨酸脱甲基化来调节各种生物学功能。 LSD1的异常调节与胃癌的发生和发展密切相关。 LSD1表达水平的变化在胃癌细胞的增殖和转移中起重要作用。其功能和机制的研究可为胃​​癌的早期诊断和靶向治疗提供理论依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号